Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Aptorum Group Limited (APM)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
1.8400-0.0700 (-3.66%)
At close: 04:00PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close1.9100
Open1.9300
Bid1.8300 x 1200
Ask1.9000 x 800
Day's Range1.8200 - 1.9300
52 Week Range1.8100 - 4.9400
Volume111,608
Avg. Volume135,672
Market Cap65.553M
Beta (5Y Monthly)-0.20
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for APM

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Aptorum Group Limited
    SPNT: Rating increased to a BUYSIRIUSPOINT LTD has an Investment Rating of BUY; a target price of $9.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of High; a Growth Subrating of Medium; and a Value Subrating of High.
    Rating
    Fair Value
    Economic Moat
    6 days agoArgus Research
View more
  • Business Wire

    Aptorum Group Limited to Hold Annual General Meeting of Shareholders on December 2, 2021

    NEW YORK & LONDON & PARIS, October 19, 2021--Regulatory News: Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) ("Aptorum Group" or "Aptorum"), a clinical stage biopharmaceutical company focused on novel technologies including the targeting of oncological diseases, announced that it will hold its 2021 annual general meeting of shareholders at Meeting Room 06, 1/F, Building 1E, Hong Kong Science Park, N.T., Hong Kong at 8:00 p.m. Hong Kong Time on December 2, 2021 (7:00 a.m. Eastern Standa

  • Business Wire

    Aptorum Group Limited Interview to Air on Bloomberg U.S.

    NEW YORK & LONDON & PARIS, October 15, 2021--Regulatory News: Aptorum Group Limited (NASDAQ: APM, Euronext Paris: APM), a clinical stage biopharmaceutical company focused on novel technologies including the targeting of oncological diseases, today announced that an interview with President Darren Lui will air on The RedChip Money Report® on Bloomberg TV Oct. 16 at 7 p.m. Eastern Time (ET).

  • Business Wire

    Aptorum Group Limited Reports Financial Results and Business Update for the Six Months Ended June 30, 2021

    NEW YORK & LONDON & PARIS, September 15, 2021--Regulatory News: Aptorum Group Limited (NASDAQ: APM, Euronext Paris: APM) ("Aptorum Group" or the "Company"), a clinical stage biopharmaceutical company dedicated to meeting unmet medical needs in oncology and infectious diseases, today provided a business update and announced financial results for the six months ended June 30, 2021.

Advertisement
Advertisement